Efficient lentiviral transduction and transgene expression in primary human B cells

Human Gene Therapy Methods

Volumn 23, Issue 6, 2012, Pages 408-415

  Mock, Ulrike ^a   Thiele, Regine ^a   Uhde, Almut ^a   Fehse, Boris ^a   Horn, Stefan ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; LENTIVIRUS VECTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GENE EXPRESSION; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN CELL; LENTIVIRINAE; MEMORY CELL; MOUSE; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; SPLEEN FOCUS FORMING VIRUS; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANTIGENS, CD40; B-LYMPHOCYTES; CELLS, CULTURED; GENETIC VECTORS; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LEUKEMIA VIRUS, GIBBON APE; MATRIX ATTACHMENT REGIONS; PROMOTER REGIONS, GENETIC; SPLEEN FOCUS-FORMING VIRUSES; TRANSDUCTION, GENETIC;

EID: 84878746105     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2012.160     Document Type: Article

References (36)

1. Arpin, C., Déchanet, J., van Kooten, C., et al. (1995). Generation of memory B cells and plasma cells in vitro. Science 268, 720-722.
2. Banerji, J., Olson, L., and Schaffner, W. (1983). A lymphocytespecific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33, 729-740. (Pubitemid 13073988)
3. Baum, C., Hegewisch-Becker, S., Eckert, H.-G., et al. (1995). Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J. Virol. 69, 7541-7547.
4. Beyer,W.R., Westphal, M., Ostertag,W., and von Laer, D. (2002). Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: Generation, concentration, and broad host range. J. Virol. 76, 1488-1495. (Pubitemid 34066448)
5. Bovia, F., Salmon, P., Matthes, T., et al. (2003). Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors. Blood 101, 1727-1733. (Pubitemid 36237567)
6. Chen, C., Rivera, A., Ron, N., et al. (2001). A gene therapy approach for treating T-cell-mediated autoimmune diseases. Blood 97, 886-894. (Pubitemid 32154270)
7. Cockerill, P.N., Yuen, M.H., and Garrard, W.T. (1987). The enhancer of the immunoglobulin heavy chain locus is flanked by presumptive chromosomal loop anchorage elements. J. Biol. Chem. 262, 5394-5397.
8. Coughlin, C.M., Vance, B.A., Grupp, S.A., and Vonderheide, R.H. (2004). RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: Implications for pediatric immunotherapy. Blood 103, 2046-2054. (Pubitemid 38326219)
9. Fernandez, L., Winkler, M., and Grosschedl, R. (2001). Matrix attachment region-dependent function of the immunoglobulin l enhancer involves histone acetylation at a distance without changes in enhancer occupancy. Mol. Cell. Biol. 21, 196-208.
10. Forrester,W.C., van Genderen, C., Jenuwein, T., and Grosschedl, R. (1994). Dependence of enhancer-mediated transcription of the immunoglobulin l gene on nuclear matrix attachment regions. Science 265, 1221-1225. (Pubitemid 24291978)
11. Frecha, C., Costa, C., Lévy, C., et al. (2009). Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus GP displaying lentiviral vectors. Blood 114, 3173-3180.
12. Frecha, C., Lévy, C., Costa, C., et al. (2011). Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors. J. Virol. 85, 5975-5985.
13. Funke, S., Maisner, A., Mü hlebach, M.D., et al. (2008). Targeted cell entry of lentiviral vectors. Mol. Ther. 16, 1427-1436.
14. Garcia-Gila, M., Lopez-Martin, E.M., and Garcia-Pardo, A. (2002). Adhesion to fibronectin via a4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas/Apo-1 receptors. Clin. Exp. Immunol. 127, 455-462. (Pubitemid 34437816)
15. Janssens, W., Chuah, M.K.L., Naldini, L., et al. (2003). Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent. Hum. Gene Ther. 14, 263-276. (Pubitemid 36423445)
16. Jenuwein, T., Forrester, W.C., Fernández-Herrero, L.A., et al. (1997). Extension of chromatin accessibility by nuclear matrix attachment regions. Nature 385, 269-272. (Pubitemid 27043728)
17. Kardava, L., Moir, S., Wang, W., et al. (2011). Attenuation of HIVassociated human B cell exhaustion by siRNA downregulation of inhibitory receptors. J. Clin. Invest. 121, 2614-2624.
18. Klein-Gonzalez, N., Balkow, S., Kondo, E., et al. (2010). CD40-activated B cells migrate towards secondary lymphoid organs and interact dynamically with T cells. Bone Marrow Transplant. 45(Suppl. 2), S1.
19. Luo, X.M., Maarschalk, E., O'Connell, R.M., et al. (2009). Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes. Blood 113, 1422-1431.
20. Lutzko, C., Senadheera, D., and Skelton, D. (2003). Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytes. J. Virol. 77, 7341-7351. (Pubitemid 36734502)
21. Miller, A.D., Garcia, J.V., Suhr, N., et al. (1991). Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65, 2220-2224.
22. Mü hlebach, M.D., Schmitt, I., Steidl, S., et al. (2003). Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes. J. Mol. Med. 81, 801-810. (Pubitemid 38058163)
23. Naldini, L., Blömer, U., Gallay, P., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267. (Pubitemid 26119138)
24. Newrzela, S., Cornils, K., Li, Z., et al. (2008). Resistance of mature T cells to oncogene transformation. Blood 112, 2278-2286.
25. Ott, M.G., Schmidt, M., Schwarzwaelder, K., et al. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401-409.
26. Perez-Andres, M., Paiva, B., Nieto, W.G., et al. (2010). Human peripheral blood B-cell compartments: A crossroad in B-cell traffic. Cytometry B Clin. Cytom. 78(Suppl. 1), S47-S60.
27. Serafini, M., Naldini, L., and Introna, M. (2004). Molecular evidence of inefficient transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivectors. Virology 325, 413-424. (Pubitemid 38902804)
28. Stitz, J., Buchholz, C.J., Engelstä dter, M., et al. (2000). Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 273, 16-20. (Pubitemid 30602003)
29. Strang, B.L., Ikeda, Y., Cosset, F.-L., et al. (2004). Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells. Gene Ther. 11, 591-598. (Pubitemid 38455977)
30. von Andrian, U.H., and Mempel, T.R. (2003). Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3, 867-878. (Pubitemid 37411716)
31. von Bergwelt-Baildon, M., Shimabukuro-Vornhagen, A., Popov, A., et al. (2006). CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: Potential as cellular adjuvants. Blood 107, 2786-2789.
32. von Kalle, C., Kiem, H.P., Goehle, S., et al. (1994). Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood 84, 2890-2897. (Pubitemid 24328075)
33. Weber, K., Bartsch, U., Stocking, C., and Fehse, B. (2008). A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. Mol. Ther. 16, 698-706.
34. Yoshida, H., Nishiura, T., Karasuno, T., et al. (1998). Effect of the interaction between fibronectin and VLA-4 on the proliferation of human B cells, especially a novel human B-cell line, OPM-3. Br. J. Haematol. 103, 804-812. (Pubitemid 28545321)
35. Zanetti, M., Castiglioni, P., Rizzi, M., et al. (2004). B lymphocytes as antigen-presenting cell-based genetic vaccines. Immunol. Rev. 199, 264-278. (Pubitemid 38736776)
36. Zhou, Q., Schneider, I.C., Gallet, M., et al. (2011). Resting lymphocyte transduction with measles virus glycoprotein pseudotyped lentiviral vectors relies on CD46 and SLAM. Virology 413, 149-152.